Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Maize variety hybrid X8N355
Multi-object appearance-enhanced fusion of camera and range sensor data
Computing infrastructure
Method of manufacturing a SiC bipolar junction transistor and SiC bipolar junction transistor thereof
Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids
Defect inspection device and defect inspection method
High temperature interconnect assemblies for high temperature electronics utilizing transition pads
  Randomly Featured Patents
Method to provide emergency health care to patients with insurance
Method for spatially controlling the period and amplitude of Bragg filters
Water-soluble epoxy resins and process for their preparation
Method of treating Theileriosis
Fundus camera
Trailer hitch
Automatic focus adjusting device
Case for plurality of contact lens
Benzothiadiazolylphenylalkylamine derivatives and methods of their use
Machining method